South Africa
Oct 28, 2024
Article and Study Summary: Article Twice-Yearly Lenacapavir or Daily F/TAF for HIV Prevention in Cisgender Women Published in: N Engl J Med. 2024;391(13):1179–1192. https://doi.org/10.1056/NEJMoa2407001 Authors: Bekker L, Das M, Abdool Karim Q, et al. for the PURPOSE...
Oct 2, 2024
The HIV Impact Network for Vertical Transmission Elimination (HIVE) is a multi-country knowledge-exchange network. HIVE collaborates with ministries of health and partner organizations in the vertical transmission prevention response, including networks of people...
Aug 27, 2024
Authors:Â Abrams EJ, Jao J, Madlala HP, Zerbe A, Catalano P, Gerschenson M, Goedecke JH, Gomba Y, Josefson J, Kurland IJ, Legbedze J, McComsey GA, Matyesini S, Mukonda E, Robinson D, Myer L. Abstract:Â Introduction Dolutegravir (DTG)-based antiretroviral therapy is...
May 13, 2024
Author:Â G. Justus Hofmeyr, Mandisa Singata-Madliki, Joanne Batting, Petrus Steyn, Katherine K. Thomas, Rodal Issema, Ivana Beesham, Enough Mbatsane, Charles Morrison, Jen Deese, Jenni Smit, Neena Philip, Thesla Palanee-Phillips, Krishnaveni Reddy, Maricianah Onono,...
Apr 9, 2024
Authors: Ana Barrios-Tascon, Renate Strehlau, Faeezah Patel, Megan Burke, Stephanie Shiau, Yanhan Shen, Stephen M Arpadi, Elaine J Abrams, Caroline T Tiemessen, Louise Kuhn; LEOPARD study team Abstract: Objective: To investigate the role of early antiretroviral...